Researchers from Stanford University looked into a possible cancer vaccine and through their clinical trials found out it is incredibly effective. Ana Kasparian, Grace Baldridge, and Mark Thompson, hosts of The Young Turks, discuss. Tell us what you think in the comment section below. http://www.tytnetwork.com/join Read more here: https://www.livescience.com/62161-cancer-vaccine-trial.html "A promising new cancer "vaccine" that cured up to 97 percent of tumors in mice will soon be tested in humans for the first time — but experts say that we're still a long way off from this type of drug being prescribed to cancer patients. Researchers from Stanford University will test the therapy in about 35 people with lymphoma by the end of the year, according to SFGate, a local news outlet in San Francisco. The treatment stimulates the body's immune system to attack cancer cells. In studies in mice with various cancers — including lymphoma, breast cancer and colon cancer — the treatment eliminated cancer tumors in 87 out of 90 mice, even when the tumors had spread to other parts of the body, the researchers said." Hosts: Ana Kasparian, Grace Baldridge, and Mark Thompson Cast: Ana Kasparian, Grace Baldridge, and Mark Thompson *** The Largest Online News Show in the World. Hosted by Cenk Uygur and Ana Kasparian. LIVE STREAMING weekdays 6-8pm ET. https://goo.gl/tJpj1m Subscribe to The Young Turks on YouTube: https://goo.gl/a3JY9i Like The Young Turks on Facebook: https://goo.gl/txrhrh Follow The Young Turks on Twitter: https://goo.gl/w6ahdV Buy TYT Merch: https://goo.gl/KVysaM Download audio and video of the full two hour show on-demand + the members-only post game show by becoming a member at https://goo.gl/v8E64M. Your membership supports the day to day operations and is vital for our continued success and growth. Young Turk (n), 1. Young progressive or insurgent member of an institution, movement, or political party. 2. A young person who rebels against authority or societal expectations.(American Heritage Dictionary)
Views: 143648 The Young Turks
Currently we only have vaccines to prevent cancers that are caused by viruses. These are the vaccines that provide protection against the human papillomavirus (HPV), which can cause cervical, anal, and head and neck cancers, and hepatitis B, which can cause liver disease and liver cancer. Researchers are trying to develop breast cancer treatment vaccines that will teach the immune system to attack cancer cells. A number of these vaccines are now being studied in clinical trials.
Views: 148 Dr. Susan Love Research Foundation
There is no vaccine for breast cancer because reason for breast cancer is development of high risk cells in the breast and high risk cells develop because of multiple reasons. There are multiple risk factors starting from age of the patient, being woman itself, large breast tissue, hereditary factor, vitamin D deficiency, radiation of the breast. So there is no vaccine for breast cancer.
Kristine Lazar reports on Sacramento woman getting remarkable results from breast-cancer vaccine (12-27-2016)
Views: 113 KPIX CBS SF Bay Area
Elizabeth Mittendorf, MD, PhD, Assistant Professor in the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center, discusses the use of peptide vaccines for the treatment of breast cancer. In her presentation at the 12th International Congress on the Future of Breast Cancer from July 18-20, 2013, in Huntington Beach, CA, Mittendorf spoke about HER2-targeted vaccine therapies. Provenge, for the treatment of metastatic castration-resistant prostate cancer, is the only FDA-approved cancer vaccine, Mittendorf notes. Treatment with Provenge involves leukapheresis, blood manipulation, and administration into the patient. This is an intricate and very expensive process, Mittendorf says. A peptide is a small piece of a protein, Mittendorf says, but is large enough to be recognized by the immune system. A peptide vaccine is given as a simple subdermal shot once per month for six months, followed by booster inoculations. If the peptide vaccine approach is proven to be efficacious, it would be cost-effective and simple to produce, making it more widely used than complex vaccine constructions. On the other hand, Mittendorf notes, peptide vaccines probably will not stimulate enough of an immune response to take care of an aggressive disease, which is why they are being investigated in the adjuvant setting. See more at: http://www.onclive.com/onclive-tv/Dr-Mittendorf-on-Peptide-Vaccines-for-Breast-Cancer#sthash.SnQDP7eG.k73IeORd.dpuf
Views: 994 Galena Biopharma
In a WPBF 25 News special report -- Tiffany Kenney follows a South Florida woman who battled breast cancer and says the vaccine helped her beat the disease. See how this cutting-edge treatment works. MORE INFO: http://www.penniesinaction.org/ Subscribe to WPBF on YouTube now for more: http://bit.ly/1qfxvbX Get more West Palm Beach news: http://www.wpbf.com/ Like us: http://www.facebook.com/wpbf25news Follow us: http://twitter.com/WPBF25News Google+: http://plus.google.com/+WPBF
Views: 45503 WPBF 25 News
South Florida woman diagnosed with breast cancer finds hope with experimental immunotherapy treatment.
Views: 111 WPLG Local 10
One in eight women in the United States is diagnosed with breast cancer. For women who survive, there’s always concern about the cancer coming back. Scientists at UW Medicine in Seattle are developing a new vaccine to try to stop such recurrences. “We’re immunizing people who have already had cancer to get their immune response up and prevent the cancer from recurring,” said Dr. Mary Disis, who directs the Cancer Vaccine Institute at the University of Washington. She and Kristi Blair, a breast-cancer survivor participating in one such clinical trial, discuss what it means to them.
Views: 85 UW Medicine
Elizabeth Mittendorf, MD, PhD, Assistant Professor in the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center, discusses the use of peptide vaccines for the treatment of breast cancer. In her presentation at the 12th International Congress on the Future of Breast Cancer from July 18-20, 2013, in Huntington Beach, CA, Mittendorf spoke about HER2-targeted vaccine therapies. For more on breast cancer: http://www.onclive.com/specialty/breast-cancer
Views: 183 OncLiveTV
Eminent doctors and other specialists from healthcare and lifestyle provide answers to your questions on health and wellness, only on Dr ETV. The question and answer session covers experts from several medical streams and is vital in providing you lifesaving and life-changing information
Views: 109 ETV Life India
Dr. Bremner talks to community members about breast cancer treatment and detection, including genetic testing, chemoprevention, screening mammograms, benign breast disease, new therapeutic treatments, breast cancer vaccines, and breast cancer in young women. There are three categories of breast cancer risk: sporadic, familial, and genetic. Eighty to ninety percent of breast cancer cases are sporadic. The women have no history of breast cancer in their family and no genetic mutations. Five to ten percent of breast cancer cases are familial. The women have close relatives (mother, sister, aunt, grandmother) who had breast cancer. The final five to ten percent of cases are genetic. These women have a heritable genetic mutation, such as BRCA1 or BRCA2, which increases their risk of developing breast cancer. Doctors use genetic testing to identify these mutations before women develop breast cancer, so they can take preventative measures. Chemoprevention is breast cancer prevention. Sixty to seventy percent of breast cancers in women over 50 is hormone positive, which means they could benefit from breast cancer risk reduction therapy, such as medications like Tamoxifin and Raloxifinem. These drugs are anti-hormones that affect the endocrine system and lower a woman’s risk of breast cancer, but are only used for high-risk patients. Other chemoprevention therapies include lifestyle changes (e.g. diet), mammogram screenings, genetic counseling, enhanced screenings (e.g. MRI), and preventative surgery. Screening mammograms should begin at age 40 and women should receive one every year. There is no upper age limit for mammograms. The decision to stop or continue is determined by the patient’s health. Not every breast lesion is malignant. Ten percent of the biopsies performed in the USA are benign. Though they’re not dangerous, they can produce a lot of anxiety in the women who have them. Some, like atypical hyperplasia, can increase your lifetime risk of breast cancer. Cancer is not one disease. Doctors have broken down the genetic makeup of cancers and found that specific types of cancer respond better to different types of cancer. This had led to the development of targeted therapies that attack different types of therapy. It’s reduced the need for aggressive therapies, like chemotherapy, in many patients and helped explain why patients respond differently to different therapies. Breast cancer vaccines are one of the most promising fields of breast cancer research. They turn the body’s immune system against the cancer cells and their effects last for a lifetime. Doctors are only giving vaccines to patients in clinical trials. So far, results are promising. In the phase two clinical trial, 94 percent of women given the vaccine did not develop breast cancer, compared to 86 percent of women in the control group. Breast cancer in younger women is typically different from breast cancer in older women. It’s very rare for women under 40 to develop breast cancer – the rate is only 1 in 200 – but the cancers they do develop tend to be more aggressive and more deadly. Young women also suffer more physically and psychologically than older women do. Young women with breast cancer are also more likely to suffer a recurrence than older women. For more information, visit our website: www.breastlink.com
Views: 158 Breastlink
Just like each patient, each cancer is unique. While patients have traditionally been treated in a one-size-fits-all manner, doctors’ ability to treat patients in a personalized manner that’s most likely to benefit them has improved significantly in the past several years. One of the most promising personalized immunotherapy approaches currently being explored in the clinic is cancer vaccines. These vaccines—especially patient-tailored versions known as neoantigen vaccines—are capable of educating patients’ immune systems about what their individual tumors “look like,” and in turn, have the potential to improve the immune system’s ability to target and eliminate cancer. In this webinar for patients and caregivers, Gavin Dunn, M.D., Ph.D., of the Siteman Cancer Center at Washington University in St. Louis, will provide an in-depth discussion of these cancer vaccines focusing on topics including but not limited to: how they’re made, how they’re being used today, and how advances currently being explored might soon make them even more beneficial for cancer patients. Dr. Dunn is currently an assistant professor in the Department of Neurological Surgery, and a member of the Center for Human Immunology and Immunotherapy Programs at the Siteman Cancer Center at the Washington University School of Medicine in St. Louis. He is also currently a CRI-funded CLIP Investigator. As both a practicing oncologist and the head of a research laboratory, Dr. Dunn is devoted to helping patients with malignant brain cancer, especially glioma. On the clinical side, Dr. Dunn is heavily involved in ongoing clinical trial efforts that are evaluating novel immunotherapies, including vaccines, for brain cancer patients. To complement his clinical efforts, the work being done in Dr. Dunn’s laboratory—currently supported in part by a Cancer Research Institute CLIP grant—aims to provide a better understanding of the genetics of brain cancers and how they interact with the immune system, in order to enhance the effectiveness of vaccine strategies. Ultimately, his goal is to leverage this knowledge to develop and refine novel immunotherapy approaches that can help improve survival for patients with this hard-to-treat cancer type. The "Cancer Immunotherapy and You" webinar series is produced by the Cancer Research Institute and is hosted by our science writer, Arthur Brodsky, Ph.D. The series is made possible with generous support from Bristol-Myers Squibb, with additional support from Regeneron, Sanofi Genzyme, and Adaptimmune. Browse our Cancer Immunotherapy and You Webinar Series playlist on YouTube or visit the Webinars page on our website to see other webinars in this series. https://www.cancerresearch.org/webinars
Views: 19434 Cancer Research Institute
www.dailyrx.com/gp2-vaccine-was-safe-and-well-tolerated-recent-trial Efforts to fight cancer include both treatment and prevention. A recently tested vaccine proved to be safe and tolerable for breast cancer patients hoping to prevent recurrence. I'm Miranda Savioli with your latest health news. Targeting protein or tumor cells is the goal of vaccine development. One protein found in some breast cancers is HER2. The GP2 vaccine was developed to teach the immune system to look for and destroy the protein. In the clinical study, participants were either given the vaccine with an immune system stimulant or just the immune system stimulant alone. The results showed the vaccine to be as safe as the immune system agent and the women tolerated it well. Breast cancer recurrence decreased by nearly 60 percent in women who got the vaccine compared to those who only received the immune system agent. Make sure to get screened regularly for breast cancer.
Views: 101 dailyRx
Every three minutes, a woman is diagnosed with breast cancer. Every thirteen minutes, a woman dies of the disease. ◂ The ABC Action News app brings you the latest trusted news and information. ABC Action News is Taking Action For You with leading local news coverage, "Certified Most Accurate" weather forecasts, and award-winning I-Team investigations. ABC Action News, WFTS, covers local news in Tampa Bay and Florida. iPhone: http://bit.ly/http://bit.ly/iOS-wfts Android: http://bit.ly/abcaction-android
Views: 359 ABC Action News
Elizabeth Mittendorf, MD, PhD, associate professor, Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, discusses discovering a predictive biomarker response in vaccine therapy for patients with breast cancer. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Views: 131 Targeted Oncology
Former Rubio Cancer Center patient Virginia McCampbell shares her story and how she survived breast cancer without surgery. She describes how immunotherapy and cancer vaccines helped her beat back cancer. Find out more at RubioCancerCenter.com.
Views: 825 rubiocancercenter
UPDATE: As of March 29th this treatment is now in human trials. Stanford CANCER VACCINE. Stanford University Cancer research had a breakthrough. Researchers from Stanford university have developed what is being called a vaccine for cancer. This cancer research breakthrough shows promise because in lab tests it successfully eliminated cancer in 87 out of 90 test mice. With a second round of injections it also cured the other 3 mice. Not only that but it also kept the mice cancer free. This treatment can be used in tumor removal before and after to not only treat the cancer but to keep it from coming back. This cancer research institute may have found a prostate cancer cure, breast cancer cure and all other cancer cure 2018. This cancer research 2018 is already in human trials and as an immunotherapy cancer treatment it doesn't have all the immunotherapy side effects of say immunotherapy prostate cancer can have by targeting the precise type of cancer so it doesnt ravage the body. So as immunotherapy treatment 2018 goes this is looking to be a good year. SOURCES: Stanford https://goo.gl/xNAqsD Paper https://goo.gl/Q7hYUi WHO https://goo.gl/kw3VX ******************************************************************** Here on ZakDTV I like tho bring the most interesting science news every Monday-Wednesday and Friday. This is the science that will change our lives forever. We will look at futuristic transportation technologies like the HyperLoop, Virgin Galactic, Tesla Motors and anything that hints at the ability to be a teleporter. I will also bring you advances in robotics from places like Boston Dynamic, iRobot, Hansen Robotics, Darpa and many more. We will see service robots being integrated into our daily lives and we will watch together as that happens. Of course the future will bring forward amazing cures and advances in gene therapy using tools like crispr/cas9. These genetic modifications will lead to a longer life and possibly even human immortality. That would truly be amazing. Of course the future wouldn't be complete without spaceflight. Things like the moon base Nasa wants to make or the ESU and their plans to go to mars. JAXA is providing some great advances as well. We will look at new satellite tech and of course anything cool with the lab in the sky our International Space Station. ********************************************************************* Follow me on: Facebook: https://www.facebook.com/ZakDTV/ Twitter : https://twitter.com/ZakDTV Instagram : https://www.instagram.com/zakdtv Gmail : ZakDTV1@gmail.com **********************************************************************
Views: 4835 ZakDTV
From ASCO 2014, Elizabeth A. Mittendorf, M.D., Ph.D., an Assistant Professor in the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center discusses the primary analysis of the prospective, randomized, single-blinded phase II trial of AE37 vaccine versus GM-CSF alone administered in the adjuvant setting to high-risk breast cancer patients.
Views: 1280 GenerexBiotechnology
Elizabeth Mittendorf, MD, PhD, Assistant Professor in the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center, gives an overview of how the E75 vaccine works in breast cancer. For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/
Views: 1479 Targeted Oncology
Elizabeth A. Mittendorf, MD, PhD, associate professor in the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center, discusses the possibility of using vaccines as a preventative measure for breast cancer, particularly to fight recurrence.
Views: 102 OncLiveTV
Cuba's Lung Cancer Vaccine Stuns But The Real Surprise Is The Price.Cuba Found A Cancer Vaccine! More Than Four Thousand People Have Already Been Cured By It.Here’s the bottom line, the for-profit cancer industry has been lying to us.Let me first say that most medical professionals have rock solid integrity and truly care about people over profits. However, we can’t ignore the inherent dark side of our current state of for-profit health care. The truth is, some cancer doctors like the criminal oncologist Dr. Farid Fata falsely diagnosed people with cancer to make money off “treating” them with deadly chemicals known as “chemotherapy.” Dr. Fata, who worked out of a state-of-the-art cancer center in Detroit, is now a convicted felon. But there are more criminals working inside the cancer industry: Oncologists, cancer surgeons, breast cancer specialists, and mammography con artists. Their goal is to scare you with a false positive diagnosis, then convince you to undergo surgery, chemotherapy or radiation therapy that you don’t even need! Cuba Found A Cancer Vaccine! More Than Four Thousand People Have Already Been Cured By It Natural | November 18, 2017 | Healthy Tips | No Comments Here’s the bottom line, the for-profit cancer industry has been lying to us. Let me first say that most medical professionals have rock solid integrity and truly care about people over profits. However, we can’t ignore the inherent dark side of our current state of for-profit health care. The truth is, some cancer doctors like the criminal oncologist Dr. Farid Fata falsely diagnosed people with cancer to make money off “treating” them with deadly chemicals known as “chemotherapy.” Dr. Fata, who worked out of a state-of-the-art cancer center in Detroit, is now a convicted felon. But there are more criminals working inside the cancer industry: Oncologists, cancer surgeons, breast cancer specialists, and mammography con artists. Their goal is to scare you with a false positive diagnosis, then convince you to undergo surgery, chemotherapy or radiation therapy that you don’t even need!কিউবা তাদের উচ্চমানের সিগারের জন্য বিখ্যাত। সে জন্য ওই দেশে ফুসফুসের ক্যানসারে আক্রান্তের সংখ্যাও খুব বেশি। বহু লোকের মৃত্যুও হয় ক্যানসারে। ক্যানসারে আক্রান্তদের বাঁচাতে সেদেশে কিন্তু নিরন্তর গবেষণা চলছে। স্টেজ থ্রিবি এবং স্টেজ ফোর ক্যানসার রোগীদের ওপর পরীক্ষা চালানো হয় নতুন তৈরি প্রতিষেধক "সিমাভ্যাক্স" দিয়ে। যা প্রকাশিত হয়েছে ক্লিনিক্যাল অঙ্কোলজি জার্নালে। "সিমাভ্যাক্স" প্রয়োগের পর অর্ধেকের বেশি সংখ্যাক ক্ষেত্রে টিউমার প্রতিরোধকারী অ্যান্টিবডি পরিমাণ বৃদ্ধি পেয়েছে।কিউবা তাদের উচ্চমানের সিগারের জন্য বিখ্যাত। সে জন্য ওই দেশে ফুসফুসের ক্যানসারে আক্রান্তের সংখ্যাও খুব বেশি। বহু লোকের মৃত্যুও হয় ক্যানসারে। ক্যানসারে আক্রান্তদের বাঁচাতে সেদেশে কিন্তু নিরন্তর গবেষণা চলছে। স্টেজ থ্রিবি এবং স্টেজ ফোর ক্যানসার রোগীদের ওপর পরীক্ষা চালানো হয় নতুন তৈরি প্রতিষেধক "সিমাভ্যাক্স" দিয়ে। যা প্রকাশিত হয়েছে ক্লিনিক্যাল অঙ্কোলজি জার্নালে। "সিমাভ্যাক্স" প্রয়োগের পর অর্ধেকের বেশি সংখ্যাক ক্ষেত্রে টিউমার প্রতিরোধকারী অ্যান্টিবডি পরিমাণ বৃদ্ধি পেয়েছে। Cuba has long been known for its high-quality cigars, and lung cancer is a major public health problem and the fourth-leading cause of death in the country. A 2007 study of patients with stages IIIB and IV lung cancer, published in the Journal of Clinical Oncology, confirmed the safety of the CimaVax and showed an increase in tumor-reducing antibody production in more than half of cases. It proved particularly effective for increased survival if the study participant was younger than 60. So far, 5,000 patients worldwide have been treated with CimaVax, including 1,000 patients in Cuba. Lee said the latest Cuban study of 405 patients, which has not yet been published, confirms earlier findings about the safety and efficacy of the vaccine. What’s more, the shot is cheap — each costs the Cuban government just $1, Wired reported. Studies have found there are no significant side effects.
Views: 3189 Wonder Box
Laura Dunford. Already 1 month into the Issels Treatment the CT scan revealed that the liver lesions disappeared. After 5 months the bone scan was virtually normal. The breast tumor shrank from 4 x 3.5 cm to pea size. Patient had gained 20 pounds. November 9th, 2006 in her own words: I am very happy and thankful. January 12, 2008: "I enjoy life and am very optimistic." The Issels Treatment is a comprehensive immunotherapy program that integrates the most effective state-of-the-art technologies, such as advanced cancer vaccines, and other safe and scientifically validated therapies. For more information on the Issels Treatment, please visit http://www.issels.com or call 1.888.447.7357.
Views: 15859 Issels Immunotherapy
Immunotherapy harnesses the power of the immune system to fight cancer. In this episode of Cancer Newsline, Dr. Elizabeth Mittendorf talks about how successes with immunotherapy in melanoma are being applied to breast cancer treatment.
Views: 464 MD Anderson Cancer Center
Elizabeth Mittendorf, MD, PhD, assistant professor in the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center, discusses the use of peptide vaccines for the treatment of breast cancer. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Views: 155 Targeted Oncology
10/24/17 BriaCell Therapeutics (OTCQB: BCTXF) develops novel immunotherapies for patients who are limited in treatment options. Company CEO, Dr. William Williams explains the potential for BriaVax, a genetically engineered whole-cell vaccine derived from a human breast cancer cell line. Subscribe NOW to Modern Wall Street: http://bit.ly/2wsU9rO Get more Modern Wall Street: Like Modern Wall Street: http://Facebook.com/modernwallstreet/ Follow Modern Wall Street: http://Twitter.com/ModernWallSt Insta Follow: http://Instagram.com/modernwallstreet/
Views: 12272 Modern Wall Street
Doctors are working on a possible vaccine for breast cancer.
Views: 62 KTNV Channel 13 Las Vegas
Download from iTunes: http://itunes.apple.com/us/itunes-u/cancer-vaccine-to-prevent/id431848216?i=116280088 A peptide vaccine appears to reduce the risk of breast cancer recurrence in women with varying levels of HER2 expression, according to research presented at this year's Annual Meeting of the American Society of Clinical Oncology (ASCO). This vaccine educates the immune system to recognize HER2 as an invader. After years of false starts, immunotherapy is a burgeoning and promising field for cancer discovery. Elizabeth Mittendorf, M.D., assistant professor in Surgical Oncology and Patrick Hwu, M.D., professor and chair of Melanoma Medical Oncology, both at MD Anderson Cancer Center, discuss the new findings as well as ongoing vaccine research in other cancers.
Views: 565 MD Anderson Cancer Center
*Breast Cancer Vaccine* A major breakthrough could be coming for patients who suffer from a particularly aggressive type of breast cancer commonly referred to as "Triple Negative." Researchers at the Mayo Clinic in Jacksonville are planning to do clinical trials for a vaccine that would hopefully prevent the disease from coming back after a patient has been treated. Triple Negative (TNBC) strikes 15-20% of breast cancer patients. Unlike most forms of breast cancer, it's not fueled by estrogen and cannot be treated with estrogen blockers like Tamoxifen. Right now, the only treatment is chemotherapy and the disease, even when treated, is likely to come back and spread. Perez is one of the top breast cancer researchers in the world. She teamed with immunologist Dr. Keith Knutson to develop the vaccine. Knutson's research has worked on treatments for both ovarian and breast cancer. Patients who are part of the trial will be treated over a six month period. Mayo Clinic researchers are collaborating with TapImmune, a Seattle-based immunotherapy company, to develop and test the vaccine.
Views: 692 Breast Cancer Answers®
Sramila Aithal, MD, medical oncologist, Cancer Treatment Centers of America, Eastern Regional Medical Center, speaks about the use of the AE37 peptide vaccine in breast cancer. The AE37 peptide vaccine is an immune stimulant that recognizes HER2/neu protein in breast cancer as foreign. The vaccine was studied in a phase II trial and the results were positive. After a 22-month follow up of a phase II trial, there was a 43% risk reduction in the vaccine arm. Aithal says that while the vaccine showed promising results in early stage breast cancer and reduced the risk of recurrence, it needs additional phase III studies before being clinically implemented. For more resources visit: http://targetedhc.com/
Views: 479 Targeted Oncology
Quynh Trinh Breast Cancer with multiple bone metastases and collapsed right lung due to multiple lung metastases, oxygen dependency 24 hours/day. Within 4 weeks of intensive non-toxic Issels Treatment dramatic improvement of the shortness of breath, no oxygen dependency anymore, patient could eat again and regained her energy. The breast lesions flattened. The Issels Treatment is a comprehensive immunotherapy program that integrates the most effective state-of-the-art technologies, such as advanced cancer vaccines, and other safe and scientifically validated therapies. For more information on the Issels Treatment, please visit http://www.issels.com or call 1.888.447.7357.
Views: 17867 Issels Immunotherapy
Never take any vaccine for any type of cancer.
Views: 357 grindall61
On Thursday, Sept. 21 at 6pm at the Idea Center at Playhouse Square, the Prevention is the Cure program will explore the revolutionary possibility of breast cancer vaccination, a preventative measure that could use a woman’s own immune system to protect herself from developing the disease. This program will feature a talk on groundbreaking vaccine research by Dr. Vincent Tuohy, along with a panel discussion featuring experts who will explore the current state of breast cancer in the United States, from incident rates to treatment paradigms. The panel will identify the scientific basis underlying a breast cancer vaccine, and address the political, scientific/medical, financial and public perception barriers that stymie the rapid progress needed to bring such a vaccination to fruition.
Views: 535 ideastream
Robert Rees answers questions on cancer stem cells and successful and potential treatments, including antibody therapy and vaccine based immunotherapy. http://ukcatalogue.oup.com/product/academic/medicine/9780199676866.do Tumor Immunology and Immunotherapy is edited by Dr Robert C. Rees, Director and Professor of Tumour Biology, The John van Geest Cancer Research Centre, Nottingham Trent University, UK. Robert is the head of a team researching prostate and breast cancer vaccine therapies. He has published extensively in the field of tumour immunology and has previously worked at The Universities of Sheffield and Nottingham and at The National Institutes of Health, Bethesda, USA. His laboratory has discovered several tumour antigens as immunotherapy targets and established many of these as biomarkers, associating with disease status. Robert has edited 3 other books on cancer immunity and he is an Editor for the journal Cancer Immunology and Immunotherapy, amongst other journals. © Oxford University Press
Views: 4977 Oxford Academic (Oxford University Press)
Breast cancer is diagnosed in more women than any other cancer, and affects small numbers of men as well. Though long considered an immunologically silent cancer, more recent data demonstrate a key role for tumor-specific immune responses in the development of breast cancer, and in its response to therapy. On October 21, 2014, Leisha A. Emens, M.D., Ph.D., an associate professor at the Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins University School of Medicine, discussed the latest research on how immunotherapies, including cancer vaccines, standard cancer drugs, and immune checkpoint inhibitors, can be used as treatments for breast cancer and gynecologic malignancies. This 45-minute online webinar, which is part of the Cancer Research Institute's Breakthroughs in Cancer Immunotherapy webinar series, are offered free to the public and feature informative updates from leaders in cancer immunotherapy, followed by a moderated Q&A. For more information on this webinar, or to register for upcoming webinars, please visit www.cancerresearch.org/webinars.
Views: 3102 Cancer Research Institute
A new study by the Stanford University School of Medicine has announced some good news when it comes to cancer and its possible treatments in the foreseeable future.
Views: 1763 The Western Journal
Jean Young, 68 years old. Already after 3 weeks into the Issels Treatment the CT scan revealed that the pleural effusion in the right lung remarkably decreased and in the left lung completely disappeared. The oxygen saturation and the blood values markedly improved. The Issels Treatment is a comprehensive immunotherapy program that integrates the most effective state-of-the-art technologies, such as advanced cancer vaccines, and other safe and scientifically validated therapies. For more information on the Issels Treatment, please visit http://www.issels.com or call 1.888.447.7357.
Views: 8938 Issels Immunotherapy
This video explains the details for a conference call with Dr. George Peoples. Dr. Peoples is a surgical oncologist. The focus of this conference call t is upon the NeuVax Breast Cancer Vaccine. The conference is hosted by My-Gale.com (see “Forums & Discussions” section at My-Gale.com for full details). Dr. George Peoples, developer of several cancer vaccines (including NeuVax), is recognized as being the primary innovator and the most significant drive in the research and development of Breast and Ovarian Cancer Vaccines. What Dr. Salk was in developing the Polio Vaccine is the equivalent space occupied by Dr. Peoples with respect to the research & development of several cancer vaccines that have been demonstrated to be safe, effective, and durable over time. Presentation by Dr. Peoples will be followed by questions, answers, and discussions on the topics of FDA-approved Cancer Vaccine Clinical Trials, R&D, updates on current trials, and the status of a number of cancer vaccines under development. (no fee. participation limited to 999 individuals)
Views: 135 My-Gale.com